Connor, Clark & Lunn Investment Management (CC&L)’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-908
| Closed | -$30.8K | – | 1418 |
|
|
2022
Q4 | $30.8K | Sell |
908
-3,987
| -81% | -$135K | ﹤0.01% | 1160 |
|
|
2022
Q3 | $241K | Sell |
4,895
-401
| -8% | -$19.7K | ﹤0.01% | 960 |
|
|
2022
Q2 | $208K | Sell |
5,296
-6,496
| -55% | -$255K | ﹤0.01% | 929 |
|
|
2022
Q1 | $435K | Sell |
11,792
-2,618
| -18% | -$96.6K | ﹤0.01% | 804 |
|
|
2021
Q4 | $1.41M | Buy |
14,410
+75
| +0.5% | +$7.33K | 0.01% | 613 |
|
|
2021
Q3 | $1.79M | Buy |
14,335
+6,962
| +94% | +$869K | 0.01% | 543 |
|
|
2021
Q2 | $925K | Buy |
7,373
+4,710
| +177% | +$591K | ﹤0.01% | 681 |
|
|
2021
Q1 | $361K | Buy |
2,663
+2,023
| +316% | +$274K | ﹤0.01% | 837 |
|
|
2020
Q4 | $58K | Buy |
+640
| New | +$58K | ﹤0.01% | 874 |
|
|
2020
Q3 | – | Sell |
-4,413
| Closed | -$376K | – | 1097 |
|
|
2020
Q2 | $376K | Buy |
+4,413
| New | +$376K | ﹤0.01% | 803 |
|